ITI Pharma and Healthcare Fund Regular vs Quant Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹437 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare TRI |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.38 |
| Manager | Rohan Korde | Sanjeev Sharma |
| ISIN Code | INF00XX01BL5 | INF966L01CG3 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | 3.47% | -2.83% |
| 6 Month | 20.7% | 3.53% |
| 1 Year | 43.48% | 31.17% |
| 3 Year | 20.61% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 37.03% | 12.42% |
| 3 Year | 32% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 20.74% | 59.34% |
| 3 Year | 19.19% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | - | - |
| Beta | - | - |
| Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Rohan Korde | Sanjeev Sharma |
| Total AUM | ₹4626 Cr | ₹39731 Cr |
| Fund Manage | 10 | 22 |
| ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 1.8 | 5.19 |
| Large Cap | 38.11 | 15.52 |
| Mid Cap | 26.43 | 18.76 |
| Small Cap | 33.66 | 60.53 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 1.8 | 5.19 |
| Pharmaceuticals & Biotechnology | 77 | 64.82 |
| Healthcare Services | 18.01 | 9.02 |
| Chemicals & Petrochemicals | 0.96 | - |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | - |
| Petroleum Products | - | 7.46 |
| Telecom - Services | - | 7.82 |
| Food Products | - | 5.69 |
Top Comparisons
ITI ELSS Tax Saver Fund Regular - Growth
3Y Returns19.66%
360 ONE ELSS Nifty 50 Tax Saver Index Fund Regular - Growth
3Y Returns0%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns4.28%
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
3Y Returns18.68%
Mahindra Manulife Mid Cap Fund - Regular Plan - Growth
3Y Returns24.72%
Nippon India Growth Fund-Growth Plan-Growth Option
3Y Returns26.16%
Mirae Asset Large & Midcap Fund - Regular Plan - Growth Option
3Y Returns14.52%
Quant Large and Mid Cap Fund-Growth
3Y Returns20.3%